A research team led by the University of Minnesota’s public health and medical schools in Minneapolis found three drugs — metformin, ivermectin and fluvoxamine — do not reduce the risk of COVID-19 hospitalizations or deaths.
Read the full post on Becker's Hospital Review - Healthcare News
